Results 101 to 110 of about 23,100 (197)

Cell surface interactome analysis identifies TSPAN4 as a negative regulator of PD‐L1 in melanoma

Molecular Oncology, EarlyView.
Using cell surface proximity biotinylation, we identified tetraspanin TSPAN4 within the PD‐L1 interactome of melanoma cells. TSPAN4 negatively regulates PD‐L1 expression and lateral mobility by limiting its interaction with CMTM6 and promoting PD‐L1 degradation.
Guus A. Franken, Andrea Abel Gutierrez, Imke van Rossum, Cornelia G. Spruijt, Michiel Vermeulen, Guido van Mierlo, Blanca Scheijen, Annemiek B. van Spriel   +7 more
wiley   +1 more source

Evolution of Population II Stars.

The Astronomical Journal, 1962
openaire   +2 more sources

PARP inhibition and pharmacological ascorbate demonstrate synergy in castration‐resistant prostate cancer

Molecular Oncology, EarlyView.
Pharmacologic ascorbate (vitamin C) increases ROS, disrupts cellular metabolism, and induces DNA damage in CRPC cells. These effects sensitize tumors to PARP inhibition, producing synergistic growth suppression with olaparib in vitro and significantly delayed tumor progression in vivo. Pyruvate rescue confirms ROS‐dependent activity.
Nicolas Gordon, Peter T. Gallagher, Orly I. Richter, Neermala Poudel Neupane, Amy C. Mandigo, Jennifer J. McCann, Emanuela Dylgjeri, Irina Vasilevskaya, Christopher McNair, Channing J. Paller, Wm. Kevin Kelly, Karen E. Knudsen, Matthew J. Schiewer, Ayesha A. Shafi   +13 more
wiley   +1 more source

LDAcoop: Integrating non‐linear population dynamics into the analysis of clonogenic growth in vitro

Molecular Oncology, EarlyView.
Limiting dilution assays (LDAs) quantify clonogenic growth by seeding serial dilutions of cells and scoring wells for colony formation. The fraction of negative wells is plotted against cells seeded and analyzed using the non‐linear modeling of LDAcoop.
Nikko Brix, Daniel Samaga, Katharina Gehr, Benedek Dankó, Mohamed Schumann, Guido Drexler, Ahmed Alnatsha, Georg Beyer, Ujjwal Mahajan, Martin Selmansberger, Julia Mayerle, Claus Belka, Horst Zitzelsberger, Kirsten Lauber   +13 more
wiley   +1 more source

Extreme properties of a compact and massive accreting black hole host in the first 500 Myr. [PDF]

Nat Commun
Tripodi R, Martis N, Markov V, Bradač M, Di Mascia F, Cammelli V, D'Eugenio F, Willott C, Curti M, Bhatt M, Gallerani S, Rihtaršič G, Singh J, Gaspar G, Harshan A, Judež J, Merida RM, Desprez G, Sawicki M, Goovaerts I, Muzzin A, Noirot G, Sarrouh GTE, Abraham R, Asada Y, Brammer G, Estrada-Carpenter V, Felicioni G, Fujimoto S, Iyer K, Mowla L, Strait V.   +31 more
europepmc   +1 more source

Radial Velocities of Population II Stars. I.

Open Astronomy, 1992
Bartkevičius A., Sperauskas J., Rastorguev A. S., Tokovinin A. A.   +3 more
openaire   +2 more sources

Plecstatin inhibits hepatocellular carcinoma tumorigenesis and invasion through cytolinker plectin

Molecular Oncology, EarlyView.
The ruthenium‐based metallodrug plecstatin exerts its anticancer effect in hepatocellular carcinoma (HCC) primarily through selective targeting of plectin. By disrupting plectin‐mediated cytoskeletal organization, plecstatin inhibits anchorage‐dependent growth, cell polarization, and tumor cell dissemination.
Zuzana Outla, Jan Kosla, Magdalena Prechova, Lukas Frick, Patricia Bortel, Yasmin Borutzki, Andrea Bileck, Christopher Gerner, Samuel M. Meier‐Menches, Selma Osmanagic‐Myers, Martin Gregor   +10 more
wiley   +1 more source

The second survey of the Saudi Acute Myocardial Infarction Registry Program: Main results and temporal changes in care (STARS-2 program). [PDF]

PLoS One
AlSaleh A, AlSaif SM, Alhadramy O, Alshehri M, Al Faraidy K, Almutairi F, Kinsara AJ, Al-Murayeh M, Ghabashi AE, Alasnag M, Hussein GA, Askar TM, Haider KH, Alharbi IA, Almokhlef A, Sayed BA, Almasswary A, Ul-Sabah Z, Kazim H, Albareda HA, Aldossari MA, Albawardi R, Alali R, Abdulhabeeb IAM, Ibrahim SM, Alasmari S, Almoghairi AM, Khoja AY, Hussain N, Aminu BS, Serafi A, Eltayeb AO, BuSaleh AH, Alsabatien B, Hamza MK, Alsharkawy R, Awwad AA, Mohamed MA, Al Habeeb MA, Shujauddin S, Ya'u JA, Attia NM, Kholaif N, Bin Ghouth NM, Youssef MKI, Qutub MA, Lawand SR, Alkutshan R, Ahmed E, Basardah A, Alhaj WI, Altaradi H, Ali M, Alqarawi W, Alhabib KF, STARS-2 Investigators.   +55 more
europepmc   +1 more source

Peroxidasin enables melanoma immune escape by inhibiting natural killer cell cytotoxicity

Molecular Oncology, EarlyView.
Peroxidasin (PXDN) is secreted by melanoma cells and binds the NK cell receptor NKG2D, thereby suppressing NK cell activation and cytotoxicity. PXDN depletion restores NKG2D signaling and enables effective NK cell–mediated melanoma killing. These findings identify PXDN as a previously unrecognized immune evasion factor and a potential target to improve
Hsu‐Min Sung, David Bickel, Lena C. M. Krause, Daria Ezeriņa, Christian Ickes, Julian Wojtachnia, Christine S. Gibhardt, Magdalena Shumanska, Khadija Wahni, Andrea Paluschkiwitz, Julia Malo Pueyo, Ekaterina Baranova, Wim Vranken, Hedwig Stanisz, Ioana Stejerean‐Todoran, Michael P. Schön, Joris Messens, Ivan Bogeski   +17 more
wiley   +1 more source

Epigenetic alterations in rotator cuff tendinopathy and degenerative cuff tears: a systematic review. [PDF]

JSES Rev Rep Tech
Hatzinger BM, Lind DRG, Felan NA, Rothrauff BB, Dornan GJ, Huard J, Millett PJ.   +6 more
europepmc   +1 more source